Sanofi (SNY): Today's Featured Health Care Loser
Sanofi (SNY) pushed the Health Care sector lower today making it today's featured Health Care loser. The sector as a whole closed the day down 0.1%. By the end of trading, Sanofi fell 23 cents (-0.7%) to $33.89 on average volume. Throughout the day, 5.5 million shares of Sanofi exchanged hands as compared to its average daily volume of 4.4 million shares. The stock ranged in price between $33.55-$34.13 after having opened the day at $33.82 as compared to the previous trading day's close of $34.12. Other company's within the Health Care sector that declined today were: Electromed Inc (ELMD), down 17.3%, Trimeris Inc (GEVA), down 15.7%, Cormedix Inc (CRMD), down 15.4%, and Telik Inc (TELK), down 13.6%. sanofi-aventis engages in the discovery, development, and distribution of therapeutic solutions to improve the lives of everyone. The company offers a range of healthcare assets, including a broad-based product portfolio in prescription drugs, OTC/OTX, generics, vaccines, and animal health. Sanofi has a market cap of $95.2 billion and is part of the drugs industry. The company has a P/E ratio of 18.9, below the average drugs industry P/E ratio of 21 and above the S&P 500 P/E ratio of 17.7. Shares are up 9.3% year to date as of the close of trading on Friday. TheStreet Ratings rates Sanofi as a buy. Among the primary strengths of the company is its expanding profit margins over time. We feel these strengths outweigh the fact that the company has had sub par growth in net income.
- You can view the full Sanofi Ratings Report.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
- Find other investment ideas from our top rated ETFs lists.
Latest Headlines about SNY
-
Biogen Wins FDA Approval of MS Pill
04:04PM 03/27/13
-
5 Trades Getting Ready to Pop This Week
11:44AM 03/26/13
-
Stocks Slip From Highs in Thin Trading
04:28PM 02/11/13
-
Stock Futures Mixed as EU Leaders Meet
09:05AM 02/11/13
-
3 Must-See Stocks Soaring on Unusual Volume
02:56PM 02/08/13
-
Aegerion CEO Speaks On Juxtapid Launch, Orphan Drug Pricing And Competition
06:15AM 01/30/13
-
Kudos To Keryx, But Can Zerenex Zing?
10:31AM 01/28/13
Latest from TheStreet Wire
-
Randgold Resources Ltd (GOLD): Today's Featured Basic Materials Laggard
05:01PM 06/18/13
-
Pinnacle West Capital Corporation (PNW): Today's Featured Utilities Laggard
05:01PM 06/18/13
-
Saks Incorporated (SKS): Today's Featured Retail Laggard
05:01PM 06/18/13
-
Catamaran Corp (CTRX): Today's Featured Computer Software & Services Laggard
05:01PM 06/18/13
-
Leucadia National Corporation (LUK): Today's Featured Food & Beverage Laggard
05:01PM 06/18/13
-
Clearwire Corp (CLWR): Today's Featured Telecommunications Laggard
05:01PM 06/18/13
-
Infosys Ltd (INFY): Today's Featured Technology Laggard
05:01PM 06/18/13
Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
TheStreet Quant Ratings
TRY IT FREENew! $49.95/yr
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
Product Features:
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Dividend Stock Advisor
TRY IT FREEJim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
